B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

TAAR1

MOLECULAR TARGET

trace amine associated receptor 1

UniProt: Q96RJ0NCBI Gene: 13486420 compounds

TAAR1 (trace amine associated receptor 1) is targeted by 20 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting TAAR1

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1Octopamine2.309
2Guanabenz1.956
3Calcimycin1.614
4Phenelzine1.393
5Riboflavin Nutritional factor found in milk, eggs, malted barley, liver, kidney, heart, and leafy vegetables.1.393
6Sertraline1.102
7Astemizole Antihistamine drug now withdrawn from1.102
8Bisphenol A-Glycidyl Methacrylate1.102
9Danazol1.102
10Equilin1.102
11Guanabenz1.102
12Sphingosine1.102
13Anthralin0.691
14Aripiprazole0.691
15Disulfiram0.691
16Fluspirilene0.691
17Nicardipine0.691
18Proguanil0.691
19Tolazoline0.691
20torin 10.691

About TAAR1 as a Drug Target

TAAR1 (trace amine associated receptor 1) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 20 compounds with documented TAAR1 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

TAAR1 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.